Don’t miss the latest developments in business and finance.

Immune cell death occurs to prevent autoimmune diseases

Image
Press Trust of India Melbourne
Last Updated : Jan 28 2013 | 6:05 PM IST

The research finding suggests that these so-called autoimmune diseases could be treated with existing medications that force long-lived immune system cells to die.

Researchers have discovered that when immune cells lack two related proteins, called Bax and Bak, the cells can attack many healthy tissues, causing severe autoimmune disease.

Bax and Bak are members of the "Bcl-2 protein family", a large group of proteins that control cell death.

Lorraine O'Reilly from the Walter and Eliza Hall Institute said it was thought that Bax and Bak acted like an irreversible switch in cells, determining when cells die by apoptosis.

In healthy cells, Bax and Bak are in an "inactive" form, but when cells are under stress or receive external signals instructing them to die, Bax and Bak switch into an "active" form that starts the destruction of the cell by apoptosis. Without Bax and Bak, cells are highly protected against apoptosis.

O'Reilly said that some immune cells that lacked the proteins Bax and Bak were able to attack healthy tissues in many organs of the body.

More From This Section

"Normally, these 'self-reactive' immune cells are deleted during development," she said.

"In the absence of Bax and Bak, enough self-reactive cells survive development to persist in the body and cause autoimmune disease in organs such as the kidneys (glomerulonephritis), similar to what is seen in the most severe form of lupus.

"Our findings confirm that defective apoptosis of immune cells can cause autoimmune disease, and that Bax and Bak are important determinants of immune cell death," researchers said.

The study provides hope for people with autoimmune diseases as Bax and Bak activity can be triggered by a new class of potential anti-cancer agents, called BH3-mimetics, which are currently in clinical trials for certain types of leukaemia in Melbourne, O'Reilly said.

"Our findings suggest that BH3-mimetics might be an exciting new option for treatment for autoimmune conditions, by activating Bax and Bak and making the self-reactive immune cells which are causing the autoimmune disease to die," she said.

  

Also Read

First Published: Jan 28 2013 | 6:05 PM IST

Next Story